Impact of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial

Impact of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial

Background: Meningococcal conjugate vaccines protect individuals directly, but also confer herd protection by interrupting carriage transmission. This Phase III observer-blind, randomised, controlled study evaluated the effects of meningococcal quadrivalent (ACWY) glycoconjugate (MenACWY-CRM) or ser...

Full description

Bibliographic Details
Main Authors: Read, Robert C., Baxter, David, Chadwick, David R., Faust, Saul N., Finn, Adam, Gordon, Stephen B., Heath, Paul T., Lewis, David J.M., Pollard, Andrew J., Turner, David P.J.
Format: Article
Published: Elsevier 2014
Subjects:
Meningococcal
carriage
vaccine
serogroup B
conjugate
herd protection
Online Access:https://eprints.nottingham.ac.uk/34178/

Internet

https://eprints.nottingham.ac.uk/34178/

Similar Items